Fatty acid synthase (FAS) levels in endothelial cells are reduced in metabolic disorders, and the absence of FAS in endothelial cells exacerbates inflammatory responses and impairs angiogenesis (117), the CD36 receptor play a key role in vascular injury (118, 119). Here, FASN is linked to Other metabolic disease.